13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

LIVN Stock Analysis & AI Quality Score

AI stock analysis and institutional research for LivaNova PLC (LIVN), a Healthcare sector company. LIVN is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), LivaNova PLC reports quarterly revenue of $362.3M, net income of $22.3M, an operating margin of 11.5%. Top institutional holders of LIVN by reported 13-F value include BlackRock,, PRIMECAP MANAGEMENT CO/CA/, FMR, based on the most recent SEC filings. LIVN trades on the Nasdaq exchange and files with the SEC under CIK 1639691. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LIVN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for LivaNova PLC directly from SEC EDGAR.

Revenue

Q1 2026

$362.3M

Net Income

Q1 2026

$22.3M

Free Cash Flow

Q1 2026

$926.0K

Operating Margin

Q1 2026

11.5%

ROIC

Q1 2026

2.8%

D/E Ratio

Q1 2026

0.24

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+20.3% YoY
$1.39BFY 2025
FY21 $1.04BFY22 $1.02BFY23 $1.15BFY25 $1.39B

Net Income

-1477.8% YoY
$-242.5MFY 2025
FY21 $-135.8MFY22 $-86.2MFY23 $17.6MFY25 $-242.5M

Operating Income

+391.1% YoY
$199.4MFY 2025
FY21 $-784.0KFY22 $-76.8MFY23 $-68.5MFY25 $199.4M

EPS (Diluted)

-1490.6% YoY
$-4.45FY 2025
FY21 $-2.68FY22 $-1.61FY23 $0.32FY25 $-4.45

Total Assets

+7.3% YoY
$2.61BFY 2025
FY21 $2.20BFY22 $2.29BFY23 $2.43BFY25 $2.61B

Total Debt

-29.5% YoY
$438.4MFY 2025
FY21 $693.4MFY22 $583.3MFY23 $621.6MFY25 $438.4M

Op. Cash Flow

+239.5% YoY
$254.3MFY 2025
FY21 $102.5MFY22 $69.9MFY23 $74.9MFY25 $254.3M

Get alerted when LIVN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for LivaNova PLC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of LIVN

Put LIVN on your watchlist

Track score changes the day LivaNova PLC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is LIVN a good stock to buy?

13F Pro's AI-powered analysis of LivaNova PLC (LIVN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for LIVN are available on the LIVN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own LIVN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling LIVN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of LivaNova PLC's investment landscape.